PMID- 10381067
OWN - NLM
STAT- MEDLINE
DCOM- 19990908
LR  - 20041117
IS  - 0315-162X (Print)
IS  - 0315-162X (Linking)
VI  - 26
IP  - 6
DP  - 1999 Jun
TI  - Successful treatment of severe muscle necrosis with intravenous immunoglobulin.
PG  - 1411-3
AB  - Intravenous immunoglobulin (IVIG) is an effective treatment for a range of 
      conditions believed to have an autoimmune basis, including inflammatory muscle 
      disease. We describe a patient with muscle disease characterized by severe 
      necrosis without clinical or biopsy evidence of inflammation or vasculitis, who 
      responded to treatment with IVIG.
FAU - McRorie, E
AU  - McRorie E
AD  - Rheumatic Diseases Unit, Western General Hospital, Edinburgh, United Kingdom.
FAU - King, M
AU  - King M
FAU - Richmond, R
AU  - Richmond R
FAU - Smith, G
AU  - Smith G
FAU - Jobanputra, P
AU  - Jobanputra P
FAU - Nuki, G
AU  - Nuki G
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - Canada
TA  - J Rheumatol
JT  - The Journal of rheumatology
JID - 7501984
RN  - 0 (Immunoglobulins, Intravenous)
RN  - EC 2.7.3.2 (Creatine Kinase)
SB  - IM
MH  - Biopsy
MH  - Creatine Kinase/blood
MH  - Female
MH  - Humans
MH  - Immunoglobulins, Intravenous/*therapeutic use
MH  - Middle Aged
MH  - Muscle, Skeletal/*pathology
MH  - Necrosis
MH  - Polymyositis/blood/*drug therapy/*pathology
EDAT- 1999/06/25 00:00
MHDA- 1999/06/25 00:01
CRDT- 1999/06/25 00:00
PHST- 1999/06/25 00:00 [pubmed]
PHST- 1999/06/25 00:01 [medline]
PHST- 1999/06/25 00:00 [entrez]
PST - ppublish
SO  - J Rheumatol. 1999 Jun;26(6):1411-3.